Setting-up COVID-19 clinical trials during the pandemic has forced all stakeholders to think outside the box and beyond their comfort zone. In this situation, it is important to be flexible and learn quickly while adapting to the new paradigms.
During this webinar we will present SGS's experiences and perspective, as well as the lessons we have learned in the setting up of COVID-19 clinical trials during the pandemic. Our experts will present hands-on examples that will then be discussed, issues explained and mitigation plans presented.
Impact of COVID-19 on:
- Regulatory activation process
- Site selection and activation
- Protocol development
- Study set-up
Dominiek Staelens, International Project Manager, SGS
After completing a PhD in Biomedical sciences at the KU Leuven (Belgium), Dominiek worked in clinical research as Clinical Operations Manager for oncology studies. In this position his focus was the site set-up and management. Later, he moved to global project management of multicentric, multinational studies where the focus is on the overall study set-up, execution and control. Dominiek has been working in clinical research for more than five years.
For further information, please contact:
t: +32 15 27 32 45